ICD10 code of Pheochromocytoma and ICD9 code

The primary ICD-10 code for pheochromocytoma is C74.1 (malignant neoplasm of medulla of adrenal gland) or D35.0 (benign neoplasm of adrenal gland), while the ICD-9 code is typically 194.0 for malignant cases or 227.0 for benign cases. Because pheochromocytoma is a rare neuroendocrine tumor, accurate coding is essential for medical record keeping and insurance authorization for specialized testing and surgery.

What is the clinical significance of these ICD codes for Pheochromocytoma?

Coding for pheochromocytoma is highly dependent on whether the tumor is classified as benign or malignant, a distinction that can be difficult to make based on histology alone. In the clinical setting, pheochromocytoma is often treated as having malignant potential, regardless of pathology. These codes are used by healthcare providers to facilitate diagnostic workups, such as plasma-free metanephrine testing, and to justify surgical interventions like adrenalectomy. Within the DiseaseMaps community, 165 people with pheochromocytoma have shared their experiences, often highlighting the importance of precise medical coding when navigating complex insurance landscapes and rare disease specialists.

How is Pheochromocytoma diagnosed and categorized?

Diagnosis of pheochromocytoma typically begins with biochemical testing to measure catecholamines and their metabolites (metanephrines). Once biochemical evidence is established, imaging such as CT or MRI is used to localize the tumor. Genetic testing is increasingly recommended, as approximately 30% to 40% of cases of pheochromocytoma are associated with an underlying hereditary syndrome. Understanding whether the tumor is part of a genetic condition like Von Hippel-Lindau (VHL) or Multiple Endocrine Neoplasia (MEN) is crucial for long-term clinical management.

What are the common medical coding distinctions for this condition?

When documenting pheochromocytoma in the electronic health record, clinicians must be precise to ensure accurate billing and patient safety. The following list outlines the primary coding considerations:

• ICD-10 C74.1: Used for malignant pheochromocytoma of the adrenal medulla.


• ICD-10 D35.0: Used for benign neoplasms of the adrenal gland, often applied to pheochromocytoma that has not shown metastatic behavior.


• ICD-9 194.0: The legacy code for malignant adrenal tumors.


• ICD-9 227.0: The legacy code for benign adrenal tumors.


• Secondary Coding: Patients with hereditary syndromes linked to pheochromocytoma may also require secondary codes for conditions like Neurofibromatosis Type 1 (NF1) or Succinate Dehydrogenase (SDH) mutations.

Why is genetic counseling recommended for patients?

Because a significant portion of pheochromocytoma cases have a genetic basis, clinical geneticists strongly recommend that patients undergo genetic screening. Identifying a germline mutation not only helps the patient but also informs family members who may be at risk of developing the same condition. Genetic counseling provides a space to discuss the psychological impact of hereditary risk, helping patients process the implications for their children and extended family members.

Next steps

• Consult with an endocrinologist or a surgical oncologist specializing in adrenal disorders to confirm your diagnosis and coding.


• Request a referral to a clinical geneticist to determine if your pheochromocytoma is hereditary.


• Join the 165 members on DiseaseMaps.org to connect with others who have navigated the diagnostic and treatment journey of this rare disease.


• Review your pathology report with your primary physician to ensure that the ICD-10 code reflects your current clinical status.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Pheochromocytoma.


• Orphanet: Rare disease database, Pheochromocytoma classification.


• OMIM (Online Mendelian Inheritance in Man): Genetic basis of Pheochromocytoma and Paraganglioma syndromes.


• National Cancer Institute (NCI): Adrenal Gland Tumor treatment protocols.